Endpoint study

Download a free study

Clinical Endpoints Study for Ulcerative Colitis

Unlock the potential of your clinical trials with the Clinical Endpoints study by ArcaScience. Designed to empower clinicians and researchers, this comprehensive studyoffers a deep dive into the most promising clinical endpoints for ulcerative colitis, enhancing the chances of successful trial outcomes.

Why Choose This Study?

  • AI-Driven Insights: Harness the power of AI with data extracted from ClinicalTrials.gov, focusing on hundreds of clinical trials published in recent years.
  • Comprehensive Coverage: Analyze data from numerous clinical trials to identify the most effective clinical endpoints for ulcerative colitis.
  • Expertly Curated: Created by the ArcaScience team to support your productivity and success in clinical trial design and evaluation.

What's Inside?

Part 1: Key Clinical Endpoints
  • Patient Compliance and Retention: Understand various dimensions associated with patient engagement, adherence, and attrition.
  • Symptom Severity Scores: Key metrics for assessing the severity of specific symptoms like bleeding and stool frequency.
  • Quality of Life Questionnaires: Instruments used to evaluate disease-specific health-related quality of life.
  • Composite Scores: Comprehensive measures that provide a holistic view of disease activity and treatment response.
Part 2: Original Language and Specific Insights
  • Gain access to original language references and detailed insights for key clinical endpoints, ensuring clarity and accuracy for your research.
Part 3: Top Endpoints for Investigated Drugs
  • Discover the most frequently used clinical endpoints for key drugs, aiding in the selection of the most relevant endpoints for your trials.
  • Comparative analysis of endpoints used in various treatments, providing a clear understanding of their effectiveness.

Key Features

  • Data-Driven: In-depth analysis of clinical trials to help you make informed decisions.
  • Patient Demographics: Inclusive of varied patient demographics for broad applicability.
  • Diverse Endpoints: Comprehensive list of clinical outcome assessments (COAs) like patient-reported outcomes (PRO), clinician-reported outcomes (ClinRO), and composite measures to guide your endpoint selection.

Additional Benefits

  • CSV File Included: Access detailed data on COAs, their context of use, and references for further analysis.
  • Expert Support: The ArcaScience team is available for consultation, ensuring you maximize the study's benefits.

Is it possible to have this product setup locally?
What kind of data are accessible?
How reliable are our outputs? 
What quality control is used to ensure reliability?